169 related articles for article (PubMed ID: 38315178)
1. Neutrophil-to-lymphocyte ratio and monocyte-to-eosinophil ratio as prognostic indicators for advanced nasopharyngeal carcinoma.
Ye M; Huang A; Yuan B; Tan G; Ai J; Liu H
Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1971-1989. PubMed ID: 38315178
[TBL] [Abstract][Full Text] [Related]
2. Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
Yang D; Li P; Meng Z; Hu X; Huang Z; Huang H; Dong H; Qin Y; Chen C; Chen X; Li Z; Zhou Z; Li Y; Kang M
Sci Rep; 2024 Apr; 14(1):9898. PubMed ID: 38688967
[TBL] [Abstract][Full Text] [Related]
3. Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients.
Chen Y; Sun J; Hu D; Zhang J; Xu Y; Feng H; Chen Z; Luo Y; Lou Y; Wu H
Cancer Manag Res; 2021; 13():8767-8779. PubMed ID: 34866938
[TBL] [Abstract][Full Text] [Related]
4. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.
Li J; Jiang R; Liu WS; Liu Q; Xu M; Feng QS; Chen LZ; Bei JX; Chen MY; Zeng YX
PLoS One; 2013; 8(12):e83069. PubMed ID: 24386144
[TBL] [Abstract][Full Text] [Related]
5. Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study.
Li J; Ye Y; Cai Y; Ji H; Qin W; Luo Y; Zhou X; Zhang Z; Xiao X; Zhang B
Front Immunol; 2024; 15():1375931. PubMed ID: 38736892
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma.
Lu A; Li H; Zheng Y; Tang M; Li J; Wu H; Zhong W; Gao J; Ou N; Cai Y
Biomed Res Int; 2017; 2017():3047802. PubMed ID: 28321405
[TBL] [Abstract][Full Text] [Related]
7. Change in the Neutrophil-to-Eosinophil Ratio After Avelumab Maintenance for Advanced Urothelial Carcinoma: The UROKYU Study.
Furubayashi N; Minato A; Tomoda T; Hori Y; Kiyoshima K; Negishi T; Haraguchi Y; Koga T; Harada K; Kuroiwa K; Fujimoto N; Nakamura M;
Anticancer Res; 2024 Apr; 44(4):1675-1681. PubMed ID: 38537962
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors.
Cao J; Chen Q; Bai X; Liu L; Ma W; Lin C; Lu F; Zhou T; Zhan J; Huang Y; Yang Y; Luo F; Zhao H
Ann Med; 2023; 55(2):2280002. PubMed ID: 38065623
[TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of neutrophil-to-lymphocyte ratio in advanced nasopharyngeal carcinoma: a large institution-based cohort study from an endemic area.
Yao JJ; Zhu FT; Dong J; Liang ZB; Yang LW; Chen SY; Zhang WJ; Lawrence WR; Zhang F; Wang SY; Sun Y; Zhou GQ
BMC Cancer; 2019 Jan; 19(1):37. PubMed ID: 30621619
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-lymphocyte ratio predicts the prognosis of stage II nasopharyngeal carcinoma.
Pan XB; Huang ST; Zhu XD
Cancer Manag Res; 2019; 11():8269-8275. PubMed ID: 31571984
[TBL] [Abstract][Full Text] [Related]
12. The Association of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio and Systemic Inflammation Response Index with Short-Term Functional Outcome in Patients with Acute Ischemic Stroke.
Zhang YX; Shen ZY; Jia YC; Guo X; Guo XS; Xing Y; Tian SJ
J Inflamm Res; 2023; 16():3619-3630. PubMed ID: 37641703
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of systemic inflammatory and nutritional indexes in locally advanced gastric cancer treated with adjuvant chemoradiotherapy after D2 dissection.
Wang SB; Chen JY; Xu C; Cao WG; Cai R; Cao L; Cai G
Front Oncol; 2022; 12():1040495. PubMed ID: 36387250
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.
Zeng X; Liu G; Pan Y; Li Y
J Cell Mol Med; 2020 Aug; 24(15):8326-8349. PubMed ID: 32603520
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era.
Li Q; Yu L; Yang P; Hu Q
Cancer Manag Res; 2021; 13():6799-6810. PubMed ID: 34512020
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of neutrophil-to-lymphocyte ratio change in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy.
Yin X; Chen H; Sun Y; Xiao L; Lu H; Guo W; Yang H; Zhou J; Fan K; Liang W
Sci Rep; 2024 May; 14(1):11984. PubMed ID: 38796631
[TBL] [Abstract][Full Text] [Related]
17. The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Jiang C; Zhang S; Qiao K; Xiu Y; Yu X; Huang Y
Clin Breast Cancer; 2022 Jul; 22(5):424-438. PubMed ID: 35428593
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma.
Jiang Y; Qu S; Pan X; Huang S; Zhu X
Oncotarget; 2018 Feb; 9(11):9992-10004. PubMed ID: 29515785
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Capacity of Systemic Inflammation Response Index, Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Platelet-to-Lymphocyte Ratio in Patients with Hypopharyngeal Squamous Cell Carcinoma.
Wang T; Lin H; Hsueh C; Lau HC; Zhou J; Gong H; Tao L; Zhou L; Wu C
ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):453-463. PubMed ID: 35709701
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.
Peng H; Luo X
Cancer Cell Int; 2019; 19():70. PubMed ID: 30962764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
